NCT03924466 2024-02-16
VUBAR
Universitair Ziekenhuis Brussel
Phase 2 Unknown
Clinical Trials
53 trialsNCT06255262 2024-02-13
Durvalumab Combined With Surufatinib as Maintenance Therapy in Patients With Advanced Biliary Tract Cancer
China Medical University, China
Phase 1/2 Unknown
NCT06074029 2024-02-08
Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy
Peking Union Medical College Hospital
Phase 1/2 Unknown
NCT04329429 2023-12-20
A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer
RemeGen Co., Ltd.
Phase 2 Unknown
NCT06171321 2023-12-14
Circulating Tumor DNA Guided Adjuvant Chemotherapy for Biliary Tract Carcinoma
Shanghai East Hospital
Phase NA Unknown
NCT04450732 2023-12-05
Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Phase 1 Unknown
NCT05935579 2023-11-15
Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT05156788 2023-08-15
Tislelizumab（Anti PD-1), Lenvatinib and GEMOX Transformation in the Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer
Shanghai Zhongshan Hospital
Phase 2 Unknown
NCT04010071 2023-03-29
Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03475953 2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2 Unknown
NCT05742750 2023-02-24
A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer
Sun Yat-sen University
Phase 1/2 Unknown
NCT05509478 2022-09-10
LEADER-001
The First Hospital of Jilin University
Phase 2 Unknown
NCT05487443 2022-08-04
The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies
First People's Hospital of Hangzhou
Phase 2/3 Unknown
NCT04460456 2022-06-30
A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors
Silverback Therapeutics
Phase 1 Unknown
NCT03110484 2022-06-15
Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study
Samsung Medical Center
Phase 2 Unknown
NCT04401709 2022-06-15
Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer
Samsung Medical Center
Phase 3 Unknown
NCT05417230 2022-06-14
RC48-ADC Combinatioed Envolizumab in Locally Advanced or Metastatic Biliary Tract Cancer With Positive HER-2
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT03898895 2022-06-02
CORRECT
Sun Yat-sen University
Phase 2 Unknown
NCT05357196 2022-05-02
PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors
SciClone Pharmaceuticals
Phase 1/2 Unknown
NCT05320497 2022-04-15
Transparent Cap-assisted SpyGlass for Biliary Stricture
Affiliated Hospital to Academy of Military Medical Sciences
Phase NA Unknown
NCT05327582 2022-04-14
An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT04608786 2022-01-11
A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract Cancer
Lee's Pharmaceutical Limited
Phase 1 Unknown
NCT04838964 2021-12-29
A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer
Shanghai Miracogen Inc.
Phase 2 Unknown
NCT05056116 2021-12-27
A Safety and Efficacy Study of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase NA Unknown
NCT04837508 2021-12-10
A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer
Shanghai Miracogen Inc.
Phase 2 Unknown
NCT04907864 2021-06-01
MIRACLE
Kyunghee University Medical Center
Phase 2 Unknown
NCT04692051 2020-12-31
A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
Huazhong University of Science and Technology
Phase 2 Unknown
NCT04333927 2020-06-23
ACCORD
Sun Yat-sen University
Phase 2 Unknown
NCT04352023 2020-04-17
Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural
National Cancer Center, Korea
Phase 2 Unknown
NCT04300959 2020-03-09
Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT03873532 2020-02-13
A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients
Hutchmed
Phase 2/3 Unknown
NCT03139487 2020-01-06
PRIORITY
Asan Medical Center
Phase 2 Unknown
NCT02943031 2019-10-18
The Effect of Individualized Precision Therapy Programs in Patients With BTC
RenJi Hospital
Phase 4 Unknown
NCT03185988 2019-07-19
Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System
Peking University
Phase 2 Unknown
NCT04004234 2019-07-09
A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT02350686 2019-05-20
XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy
Samsung Medical Center
Phase 2 Unknown
NCT01821248 2019-02-21
A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis
Kansai Hepatobiliary Oncology Group
Phase 2 Unknown
NCT03609489 2018-08-09
A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma
First Affiliated Hospital of Guangxi Medical University
Phase 2 Unknown
NCT03427242 2018-02-09
Apatinib for Advanced Biliary Carcinoma
Fudan University
Phase 2 Unknown
NCT01859728 2018-01-18
GAMBIT
Barretos Cancer Hospital
Phase 2 Unknown
NCT03311789 2017-10-17
Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCs
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT02479984 2017-09-14
Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer
National Cancer Center, Korea
Phase NA Unknown
NCT02527824 2017-08-23
Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer
Hallym University Medical Center
Phase 2 Unknown
NCT03144856 2017-05-09
Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers
Sun Yat-sen University
Phase 2 Unknown
NCT03063554 2017-02-24
BILPAL
Weill Medical College of Cornell University
Phase NA Unknown
NCT01695447 2017-01-26
Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy
Zhejiang University
Phase NA Unknown
NCT02189421 2015-11-03
Multibending vs Conventional Endoscope for Direct Peroral Cholangioscopy
Soonchunhyang University Hospital
Phase NA Unknown
NCT02255669 2015-02-12
Fully Covered SEMS Versus Partially Covered SEMS With Anti-migration System for Malignant Distal Biliary Obstruction
Samsung Medical Center
Phase NA Unknown
NCT01811277 2013-03-15
SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer
Peking University
Phase 2 Unknown
NCT01542281 2012-03-02
Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for Cancer
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase NA Unknown